Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis

Background: Little is known about risk factors for neuromyelitis optica (NMO) or transverse myelitis (TM). Objective: The objective of this paper is to evaluate whether established multiple sclerosis (MS) risk factors, including smoking history, a history of infectious mononucleosis (IM), anti-EBNA1 Ab titers and HLA-DR15 are associated with NMO or TM. Methods: We conducted a case-control study among participants in the Accelerated Cure Project for Multiple Sclerosis (ACP) Repository, which includes patients with MS, NMO and TM. Controls include related and unrelated individuals without evidence of demyelinating disease. Analyses included 1237 cases of MS, 98 cases of NMO, 133 cases of TM and 488 healthy controls. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to assess the association between smoking, HLA-DR15, anti-EBNA1 Ab titers and a history of IM adjusting for gender, study site and ethnicity. Results: Overall, the association between smoking, IM, HLA-DR15 and anti-EBNA1 Ab titers and odds of MS were as expected and no significant interactions were observed. However, there was little evidence of association between these MS risk factors and odds of NMO or TM. Conclusions: Established MS risk factors do not appear to be associated with susceptibility to TM or NMO and, among MS patients, these risk factors appear to act independently.

[1]  R. Marrie,et al.  The incidence and prevalence of neuromyelitis optica: a systematic review. , 2013, International journal of MS care.

[2]  K. Dear,et al.  Current and past Epstein-Barr virus infection in risk of initial CNS demyelination , 2011, Neurology.

[3]  A. Ascherio,et al.  Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel , 2011, Multiple sclerosis.

[4]  F. Lolli,et al.  Neuromyelitis optica: An update , 2011, Journal of the Neurological Sciences.

[5]  C. Exley COMBINED EFFECTS OF SMOKING, ANTI-EBNA ANTIBODIES, AND HLA-DRB1*1501 ON MULTIPLE SCLEROSIS RISK , 2010, Neurology.

[6]  M. Gershwin,et al.  The epidemiology of transverse myelitis. , 2010, Autoimmunity reviews.

[7]  A. Sadovnick,et al.  Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis , 2010, Multiple sclerosis.

[8]  P. Sundström,et al.  Antibodies to specific EBNA-1 domains and HLA DRB1⁎1501 interact as risk factors for multiple sclerosis , 2009, Journal of Neuroimmunology.

[9]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[10]  Sreeram V Ramagopalan,et al.  Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility , 2009, Proceedings of the National Academy of Sciences.

[11]  R. Steffensen,et al.  Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis , 2009, Multiple sclerosis.

[12]  L. Nyström,et al.  EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study , 2008, Multiple sclerosis.

[13]  J. Rioux,et al.  Integrating risk factors , 2008, Neurology.

[14]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[15]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[16]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[17]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[18]  A. Ascherio,et al.  Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. , 2006, Archives of neurology.

[19]  D Spiegelman,et al.  Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. , 2001, JAMA.

[20]  W D Flanders,et al.  Sample size requirements in case-only designs to detect gene-environment interaction. , 1997, American journal of epidemiology.

[21]  J. Salzer Environmental risk factors for multiple sclerosis , 2013 .

[22]  Andrea T Borchers,et al.  Transverse myelitis. , 2012, Autoimmunity reviews.

[23]  E. Kieff Epstein-Barr virus and its replication , 1996 .

[24]  A. Sadovnick,et al.  Genetics of Multiple Sclerosis , 1995, Neurologic clinics.

[25]  M. Graffar [Modern epidemiology]. , 1971, Bruxelles medical.